ChromaDex Establishes Agreement with NIHChromaDex Establishes Agreement with NIH
June 24, 2009
IRVINE, Calif.—ChromaDex Corp., a leader in phytochemical reference standards and contract research, announced the National Institutes of Health established a Blanket Purchase Agreement (BPA) with the company. The agreement covers all products and services offered by ChromaDex. This includes botanical reference materials, phytochemicals, bulk chemical production, analytical testing services, analytical method development, contract research, isolation of compounds, chemical synthesis and natural product libraries. The BPA makes it easier for the various Institutes within NIH to do business with ChromaDex.
"We are honored to be recognized by the NIH with the issuance of a Blanket Purchase Agreement to ChromaDex," said Frank Jaksch, co-founder and CEO of ChromaDex. "There is considerable work taking place at NIH in the areas of natural products, dietary supplements and alternative medicines. As a leader in this field, ChromaDex will be working closely with NIH to provide products and services to support their efforts."
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023